相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhaled Nitric Oxide Decreases Leukocyte Trafficking in the Neonatal Mouse Lung During Exposure to >95% Oxygen
Melissa J. Rose et al.
PEDIATRIC RESEARCH (2010)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Is vascular biology in preeclampsia better?
L. Myatt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
Valeria C. Sandrim et al.
HYPERTENSION (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Oxidative stress, gene expression, and protein changes induced in the human placenta during labor
Tereza Cindrova-Davies et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Autocrine VEGF signaling is required for vascular homeostasis
Sunyoung Lee et al.
CELL (2007)
Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1
A. Makris et al.
KIDNEY INTERNATIONAL (2007)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
Latest advances in understanding preeclampsia
CW Redman et al.
SCIENCE (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia
CE Leik et al.
HYPERTENSION (2004)
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension
SK Nadar et al.
THROMBOSIS RESEARCH (2004)
Cytotrophoblasts up-regulate soluble Fms-like tyrosine kinase-1 expression under reduced oxygen: An implication for the placental vascular development and the pathophysiology of preeclampsia
T Nagamatsu et al.
ENDOCRINOLOGY (2004)
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
S Ahmad et al.
CIRCULATION RESEARCH (2004)
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
M Autiero et al.
NATURE MEDICINE (2003)
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia
SE Maynard et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
V Eremina et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences
V Tsatsaris et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism
HP Gerber et al.
NATURE (2002)
Vascular protection - A novel nonangiogenic cardiovascular role for vascular endothelial growth factor
I Zachary et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
